![]()
|
|
||||||||
J. Biol. Chem., Vol. 276, Issue 49, 45762-45771, December 7, 2001
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
From the Recombinant forms of the dengue 2 virus NS3
protease linked to a 40-residue co-factor, corresponding to part of
NS2B, have been expressed in Escherichia coli and shown to
be active against para-nitroanilide substrates comprising
the P6-P1 residues of four substrate cleavage sequences. The enzyme is
inactive alone or after the addition of a putative 13-residue co-factor
peptide but is active when fused to the 40-residue co-factor, by either a cleavable or a noncleavable glycine linker. The NS4B/NS5 cleavage site was processed most readily, with optimal processing conditions being pH 9, I = 10 mM, 1 mM
CHAPS, 20% glycerol. A longer 10-residue peptide corresponding to the
NS2B/NS3 cleavage site (P6-P4') was a poorer substrate than the
hexapeptide (P6-P1) para-nitroanilide substrate under these
conditions, suggesting that the prime side substrate residues did not
contribute significantly to protease binding. We also report the first
inhibitors of a co-factor-complexed, catalytically active flavivirus
NS3 protease. Aprotinin was the only standard serine protease inhibitor
to be active, whereas a number of peptide substrate analogues were
found to be competitive inhibitors at micromolar concentrations.
Activity of Recombinant Dengue 2 Virus NS3 Protease in the
Presence of a Truncated NS2B Co-factor, Small Peptide Substrates, and
Inhibitors*
,
,
,
,
¶
Centre for Drug Design and Development,
Institute for Molecular Bioscience and § Department of
Microbiology and Parasitology, School of Molecular and Microbial
Sciences, University of Queensland,
Brisbane, Queensland 4072, Australia
*
This work was supported in part by the National Health and
Medical Research Council of Australia and the Australian Research Council.The costs of publication of this
article were defrayed in part by the
payment of page charges. The article
must therefore be hereby marked
"advertisement" in
accordance with 18 U.S.C. Section
1734 solely to indicate this fact.
This article has been cited by other articles:
![]() |
I. Radichev, S. A. Shiryaev, A. E. Aleshin, B. I. Ratnikov, J. W. Smith, R. C. Liddington, and A. Y. Strongin Structure-based mutagenesis identifies important novel determinants of the NS2B cofactor of the West Nile virus two-component NS2B-NS3 proteinase J. Gen. Virol., March 1, 2008; 89(3): 636 - 641. [Abstract] [Full Text] [PDF] |
||||
![]() |
G. T. Le, G. Abbenante, and D. P. Fairlie Profiling the Enzymatic Properties and Inhibition of Human Complement Factor B J. Biol. Chem., November 30, 2007; 282(48): 34809 - 34816. [Abstract] [Full Text] [PDF] |
||||
![]() |
K. Lohr, J. E. Knox, W. Y. Phong, N. L. Ma, Z. Yin, A. Sampath, S. J. Patel, W.-L. Wang, W.-L. Chan, K. R. R. Rao, et al. Yellow fever virus NS3 protease: peptide-inhibition studies J. Gen. Virol., August 1, 2007; 88(8): 2223 - 2227. [Abstract] [Full Text] [PDF] |
||||
![]() |
E. Barklis, A. Still, M. I. Sabri, A. J. Hirsch, J. Nikolich-Zugich, J. Brien, T. C. Dhenub, I. Scholz, and A. Alfadhli Sultam Thiourea Inhibition of West Nile Virus Antimicrob. Agents Chemother., July 1, 2007; 51(7): 2642 - 2645. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. A. Shiryaev, B. I. Ratnikov, A. E. Aleshin, I. A. Kozlov, N. A. Nelson, M. Lebl, J. W. Smith, R. C. Liddington, and A. Y. Strongin Switching the Substrate Specificity of the Two-Component NS2B-NS3 Flavivirus Proteinase by Structure-Based Mutagenesis J. Virol., May 1, 2007; 81(9): 4501 - 4509. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. K. Bera, R. J. Kuhn, and J. L. Smith Functional Characterization of cis and trans Activity of the Flavivirus NS2B-NS3 Protease J. Biol. Chem., April 27, 2007; 282(17): 12883 - 12892. [Abstract] [Full Text] [PDF] |
||||
![]() |
K. J. Chappell, M. J. Stoermer, D. P. Fairlie, and P. R. Young Insights to Substrate Binding and Processing by West Nile Virus NS3 Protease through Combined Modeling, Protease Mutagenesis, and Kinetic Studies J. Biol. Chem., December 15, 2006; 281(50): 38448 - 38458. [Abstract] [Full Text] [PDF] |
||||
![]() |
C.-Y. Yu, Y.-W. Hsu, C.-L. Liao, and Y.-L. Lin Flavivirus Infection Activates the XBP1 Pathway of the Unfolded Protein Response To Cope with Endoplasmic Reticulum Stress J. Virol., December 1, 2006; 80(23): 11868 - 11880. [Abstract] [Full Text] [PDF] |
||||
![]() |
B. A. M. Pastorino, C. N. Peyrefitte, M. Grandadam, M. C. E. Thill, H. J. Tolou, and M. Bessaud Mutagenesis analysis of the NS2B determinants of the Alkhurma virus NS2B-NS3 protease activation. J. Gen. Virol., November 1, 2006; 87(Pt 11): 3279 - 3283. [Abstract] [Full Text] [PDF] |
||||
![]() |
F. Puig-Basagoiti, M. Tilgner, B. M. Forshey, S. M. Philpott, N. G. Espina, D. E. Wentworth, S. J. Goebel, P. S. Masters, B. Falgout, P. Ren, et al. Triaryl pyrazoline compound inhibits flavivirus RNA replication. Antimicrob. Agents Chemother., April 1, 2006; 50(4): 1320 - 1329. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. Li, S. P. Lim, D. Beer, V. Patel, D. Wen, C. Tumanut, D. C. Tully, J. A. Williams, J. Jiricek, J. P. Priestle, et al. Functional Profiling of Recombinant NS3 Proteases from All Four Serotypes of Dengue Virus Using Tetrapeptide and Octapeptide Substrate Libraries J. Biol. Chem., August 5, 2005; 280(31): 28766 - 28774. [Abstract] [Full Text] [PDF] |
||||
![]() |
K. J. Chappell, T. A. Nall, M. J. Stoermer, N.-X. Fang, J. D. A. Tyndall, D. P. Fairlie, and P. R. Young Site-directed Mutagenesis and Kinetic Studies of the West Nile Virus NS3 Protease Identify Key Enzyme-Substrate Interactions J. Biol. Chem., January 28, 2005; 280(4): 2896 - 2903. [Abstract] [Full Text] [PDF] |
||||
![]() |
P. Niyomrattanakit, P. Winoyanuwattikun, S. Chanprapaph, C. Angsuthanasombat, S. Panyim, and G. Katzenmeier Identification of Residues in the Dengue Virus Type 2 NS2B Cofactor That Are Critical for NS3 Protease Activation J. Virol., December 15, 2004; 78(24): 13708 - 13716. [Abstract] [Full Text] [PDF] |
||||
![]() |
T. A. Nall, K. J. Chappell, M. J. Stoermer, N.-X. Fang, J. D. A. Tyndall, P. R. Young, and D. P. Fairlie Enzymatic Characterization and Homology Model of a Catalytically Active Recombinant West Nile Virus NS3 Protease J. Biol. Chem., November 19, 2004; 279(47): 48535 - 48542. [Abstract] [Full Text] [PDF] |
||||
![]() |
T. J. Milne, G. Abbenante, J. D. A. Tyndall, J. Halliday, and R. J. Lewis Isolation and Characterization of a Cone Snail Protease with Homology to CRISP Proteins of the Pathogenesis-related Protein Superfamily J. Biol. Chem., August 15, 2003; 278(33): 31105 - 31110. [Abstract] [Full Text] [PDF] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| All ASBMB Journals | Molecular and Cellular Proteomics |
| Journal of Lipid Research | ASBMB Today |